ANTIBODIES TO CD122
The invention provides monoclonal antibodies that specifically bind to CD122, which is one component of receptors for IL-2 and IL-15. The monoclonal antibodies have the capacity for substantial inhibition of both IL-2 and IL-15 mediated functions by inhibiting binding of these cytokines to their rec...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
12.10.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides monoclonal antibodies that specifically bind to CD122, which is one component of receptors for IL-2 and IL-15. The monoclonal antibodies have the capacity for substantial inhibition of both IL-2 and IL-15 mediated functions by inhibiting binding of these cytokines to their receptors. The monoclonal antibodies can be used for inhibiting undesired immune responses or treatment of cancer, among other applications. |
---|---|
Bibliography: | Application Number: EP20110766761 |